Zainab Jan

Zainab Jan

Auto-generated profile, based on publicly available information

Zainab Jan

College of Health and Life Sciences, Hamad Bin Khalifa University, Doha, Qatar

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 November 2021 in Journal of Medical Internet Research
Verified
Journal Article
Open access
ZJZainab Jan
Zainab Jan
NANoor Ai-Ansari
Noor Ai-Ansari
OMOsama Mousa
Osama Mousa
AAAlaa Abd-alrazaq
Alaa Abd-alrazaq
AAArfan Ahmed
Arfan Ahmed
MHMowafa Househ
Mowafa Househ
Background: Bipolar disorder (BD) is the 10th most common cause of frailty in young individuals and has triggered morbidity and mortality worldwide. Patients with BD have a life expectancy 9 to 17 years lower than that of normal people. BD is a predominant mental disorder, but it can be misdiagnosed as depressive disorder, which leads to difficulties in treating affected patients. Approximately 60% of patients with BD are treated for depression. However, machine learning provides advanced skills and techniques for better diagnosis of BD. Objective: This review aims to explore the machine learning algorithms used for the detection and diagnosis of bipolar disorder and its subtypes. Methods: The study protocol adopted the PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews) guidelines. We explored 3 databases, namely Google Scholar, ScienceDirect, and PubMed. To enhance the search, we performed backward screening of all the references of the included studies. Based on the predefined selection criteria, 2 levels of screening were performed: title and abstract review, and full review of the articles that met the inclusion criteria. Data extraction was performed independently by all investigators. To synthesize the extracted data, a narrative synthesis approach was followed. Results: We retrieved 573 potential articles were from the 3 databases. After preprocessing and screening, only 33 articles that met our inclusion criteria were identified. The most commonly used data belonged to the clinical category (19, 58%). We identified different machine learning models used in the selected studies, including classification models (18, 55%), regression models (5, 16%), model-based clustering methods (2, 6%), natural language processing (1, 3%), clustering algorithms (1, 3%), and deep learning–based models (3, 9%). Magnetic resonance imaging data were most commonly used for classifying bipolar patients compared to other groups (11, 34%), whereas microarray expression data sets and genomic data were the least commonly used. The maximum ratio of accuracy was 98%, whereas the minimum accuracy range was 64%. Conclusions: This scoping review provides an overview of recent studies based on machine learning models used to diagnose patients with BD regardless of their demographics or if they were compared to patients with psychiatric diagnoses. Further research can be conducted to provide clinical decision support in the health industry.

31 March 2023 in Journal of Medical Internet Research
Verified
Journal Article
Open access
ZJZainab Jan
Zainab Jan
FAFarah Assadi
Farah Assadi
AAAlaa Abd-alrazaq
Alaa Abd-alrazaq
PJPuthen Veettil Jithesh
Puthen Veettil Jithesh
Background: Pancreatic cancer is the 12th most common cancer worldwide, with an overall survival rate of 4.9%. Early diagnosis of pancreatic cancer is essential for timely treatment and survival. Artificial intelligence (AI) provides advanced models and algorithms for better diagnosis of pancreatic cancer. Objective: This study aims to explore AI models used for the prediction and early diagnosis of pancreatic cancers as reported in the literature. Methods: A scoping review was conducted and reported in line with the PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews) guidelines. PubMed, Google Scholar, Science Direct, BioRXiv, and MedRxiv were explored to identify relevant articles. Study selection and data extraction were independently conducted by 2 reviewers. Data extracted from the included studies were synthesized narratively. Results: Of the 1185 publications, 30 studies were included in the scoping review. The included articles reported the use of AI for 6 different purposes. Of these included articles, AI techniques were mostly used for the diagnosis of pancreatic cancer (14/30, 47%). Radiological images (14/30, 47%) were the most frequently used data in the included articles. Most of the included articles used data sets with a size of <1000 samples (11/30, 37%). Deep learning models were the most prominent branch of AI used for pancreatic cancer diagnosis in the studies, and the convolutional neural network was the most used algorithm (18/30, 60%). Six validation approaches were used in the included studies, of which the most frequently used approaches were k-fold cross-validation (10/30, 33%) and external validation (10/30, 33%). A higher level of accuracy (99%) was found in studies that used support vector machine, decision trees, and k-means clustering algorithms. Conclusions: This review presents an overview of studies based on AI models and algorithms used to predict and diagnose pancreatic cancer patients. AI is expected to play a vital role in advancing pancreatic cancer prediction and diagnosis. Further research is required to provide data that support clinical decisions in health care.

9 July 2023 in Journal of Biomolecular Structure and Dynamics
Verified
Journal Article
Open access
ZJZainab Jan
Zainab Jan
WAWesam S. Ahmed
Wesam S. Ahmed
KBKabir H Biswas
Kabir H Biswas
PJPuthen Veettil Jithesh
Puthen Veettil Jithesh
DNA methyltransferases (DNMTs) play an important role in the epigenetic regulation of gene expression through the methylation of DNA. Since hypermethylation and consequent suppression of tumor suppressor genes are associated with cancer development and progression, DNA hypomethylating agents (HMAs) such as DNMT inhibitors have been proposed for cancer therapy. Two nucleoside analogues approved for the treatment of hematological cancers, decitabine and azacytidine, have poor pharmacokinetic properties, and hence there is a critical need for identifying novel HMAs. Virtual screening of a library of ∼40,000 compounds from the ZINC database, followed by molecular docking of 4,000 compounds having potential druggable properties with DNMT1, DNMT3A and DNMT3B were performed. One unique inhibitor (ZINC167686681) was identified that successfully passed through the Lipinski Rule of 5, geometry constraints as well as ADME/Tox filters and having strong binding energy for DNMTs. Further, molecular dynamics simulations of the docked complexes showed detailed structural features critical for its binding with the DNMTs and the stability of their interaction. Our study identified a compound with potential druggable properties and predicted to bind and inhibit DNMTs. Further investigations involving cellular and animal models of ZINC167686681 will help in potentially taking it into clinical trials for the treatment of cancers.Communicated by Ramaswamy H. Sarma.

11 November 2022 in JMIR Preprints
Verified
Preprint
Open access
ZJZainab Jan
Zainab Jan
FAFarah Assadi
Farah Assadi
AAAlaa Abd-alrazaq
Alaa Abd-alrazaq
PJPuthen Veettil Jithesh
Puthen Veettil Jithesh
BACKGROUND Pancreatic cancer is the 12th most common cancer worldwide, with an overall survival rate of 4.9%. Early diagnosis of pancreatic cancer is essential for timely treatment and survival. Artificial intelligence (AI) provides advanced models and algorithms for better diagnosis of pancreatic cancer. OBJECTIVE This study aims to explore AI models used for the prediction and early diagnosis of pancreatic cancers as reported in the literature. METHODS A scoping review was conducted and reported in line with the PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews) guidelines. PubMed, Google Scholar, Science Direct, BioRXiv, and MedRxiv were explored to identify relevant articles. Study selection and data extraction were independently conducted by 2 reviewers. Data extracted from the included studies were synthesized narratively. RESULTS Of the 1185 publications, 30 studies were included in the scoping review. The included articles reported the use of AI for 6 different purposes. Of these included articles, AI techniques were mostly used for the diagnosis of pancreatic cancer (14/30, 47%). Radiological images (14/30, 47%) were the most frequently used data in the included articles. Most of the included articles used data sets with a size of <1000 samples (11/30, 37%). Deep learning models were the most prominent branch of AI used for pancreatic cancer diagnosis in the studies, and the convolutional neural network was the most used algorithm (18/30, 60%). Six validation approaches were used in the included studies, of which the most frequently used approaches were k-fold cross-validation (10/30, 33%) and external validation (10/30, 33%). A higher level of accuracy (99%) was found in studies that used support vector machine, decision trees, and k-means clustering algorithms. CONCLUSIONS This review presents an overview of studies based on AI models and algorithms used to predict and diagnose pancreatic cancer patients. AI is expected to play a vital role in advancing pancreatic cancer prediction and diagnosis. Further research is required to provide data that support clinical decisions in health care.

6 September 2024
Verified
Conference Paper
Open access
SBSyed Abdullah Basit
Syed Abdullah Basit
ZJZainab Jan
Zainab Jan
LSLuma Srour
Luma Srour
SMSaleh Musleh
Saleh Musleh
Rizwan QureshiRizwan Qureshi
Rizwan Qureshi
Tanvir AlamTanvir Alam
Tanvir Alam
Non-small cell lung carcinoma (NSCLC) is the second most common cancer type worldwide. It is a type of lung malignancy that initially starts in the lung and may spread to other parts of the human body. Mutations in the epidermal growth factor receptor (EGFR), play a significant role in cell growth and malignancy. EGFR is also considered a major driver oncogene in NSCLC. Thus, several targeted drugs, like tyrosine kinase inhibitors (TKIs), i.e., Gefitinib, have been developed and approved by the FDA against the EGFR. Tyrosine kinase inhibitor (TKI) drug usage has shown an improved survival rate. However, the possibility of drug resistance threatens treatment plans and efficacy. Computational methods, such as, molecular dynamics simulation, have been developed to calculate the binding stability of WT and mutant EGFR. In this study, we investigate the performance of molecular dynamics simulation (MD simulation) tools - GROMACS, NAMD, and BioExcel - on the EGFR-Gefitinib complex, focusing on the catalytic site mutation G719S. The analysis of conformational changes in both WT and mutant EGFR-Gefitinib complexes after simulation revealed structural alterations. Comparative analysis across different time scales highlights the efficacy of NAMD and GROMACS over BioExcel, particularly evident in root mean square deviation and root mean square fluctuations. This investigation sheds light on the optimal use of MD simulation tools for studying large protein complexes, helping in the development of targeted therapies for NSCLC and other cancer types.

19 April 2021 in JMIR Preprints
Verified
Preprint
Open access
ZJZainab Jan
Zainab Jan
NANoor Ai-Ansari
Noor Ai-Ansari
OMOsama Mousa
Osama Mousa
AAAlaa Abd-alrazaq
Alaa Abd-alrazaq
AAArfan Ahmed
Arfan Ahmed
MHMowafa Househ
Mowafa Househ
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Bipolar disorder (BD) is the 10th most common cause of frailty in young individuals and has triggered morbidity and mortality worldwide. Patients with BD have a life expectancy 9 to 17 years lower than that of normal people. BD is a predominant mental disorder, but it can be misdiagnosed as depressive disorder, which leads to difficulties in treating affected patients. Approximately 60% of patients with BD are treated for depression. However, machine learning provides advanced skills and techniques for better diagnosis of BD. Objective: This review aims to explore the machine learning algorithms used for the detection and diagnosis of bipolar disorder and its subtypes. Methods: The study protocol adopted the PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews) guidelines. We explored 3 databases, namely Google Scholar, ScienceDirect, and PubMed. To enhance the search, we performed backward screening of all the references of the included studies. Based on the predefined selection criteria, 2 levels of screening were performed: title and abstract review, and full review of the articles that met the inclusion criteria. Data extraction was performed independently by all investigators. To synthesize the extracted data, a narrative synthesis approach was followed. Results: We retrieved 573 potential articles were from the 3 databases. After preprocessing and screening, only 33 articles that met our inclusion criteria were identified. The most commonly used data belonged to the clinical category (19, 58%). We identified different machine learning models used in the selected studies, including classification models (18, 55%), regression models (5, 16%), model-based clustering methods (2, 6%), natural language processing (1, 3%), clustering algorithms (1, 3%), and deep learning–based models (3, 9%). Magnetic resonance imaging data were most commonly used for classifying bipolar patients compared to other groups (11, 34%), whereas microarray expression data sets and genomic data were the least commonly used. The maximum ratio of accuracy was 98%, whereas the minimum accuracy range was 64%. Conclusions: This scoping review provides an overview of recent studies based on machine learning models used to diagnose patients with BD regardless of their demographics or if they were compared to patients with psychiatric diagnoses. Further research can be conducted to provide clinical decision support in the health industry.